Ionis Pharmaceuticals, Inc.
Modulators of YAP1 expression
Last updated:
Abstract:
The present embodiments provide methods, compounds, and compositions useful for inhibiting YAP1 expression, which may be useful for treating, preventing, or ameliorating a cancer associated with YAP1.
Status:
Grant
Type:
Utility
Filling date:
31 Jan 2020
Issue date:
4 Jan 2022